Back to top

Bernstein Sticks to Their Buy Rating for GlaxoSmithKline (GSK)

Bernstein analyst Justin Smith maintained a Buy rating on GlaxoSmithKline today and set a price target of £30.10. Smith covers the Healthcare secto...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

GSK PLC Sponsored ADR (GSK)